Simranjit Kaur
Overview
Explore the profile of Simranjit Kaur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
605
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur S, Kumari D, Dandekar M
Mol Neurobiol
. 2025 Jan;
PMID: 39775480
Alzheimer's disease (AD) is a major devastating neurodegenerative disorder afflicting majorly the geriatric population. Emerging studies augur the connection of gut dysbiosis and circadian disruption with the early onset of...
2.
Ghosh A, Verma A, Kaur S, Ahuja C, Nehra R, Singh P, et al.
Am J Drug Alcohol Abuse
. 2024 Dec;
50(6):819-830.
PMID: 39652814
Cortical differences in thickness, folding, and complexity may reflect synaptic pruning and myelination alterations. Individuals with opioid use disorder (OUD) may demonstrate differences in these cortical metrics due to neurodevelopmental...
3.
Kumari D, Kaur S, Dandekar M
ACS Pharmacol Transl Sci
. 2024 Oct;
7(10):2936-2950.
PMID: 39416963
The secondary insult in the aftermath of traumatic brain injury (TBI) causes detrimental and self-perpetuating alteration in cells, resulting in aberrant function and the death of neuronal cells. The secondary...
4.
Luthra K, Sarangal V, Singh S, Kaur S, Suchdev V
Bioinformation
. 2024 Oct;
20(8):877-881.
PMID: 39411769
The potential of Bio-Oss® collagen xenograft for treating intrabony defects using minimally invasive surgical methods is of interest. Hence, 30 defect sites in individuals with mild to severe chronic periodontitis...
5.
Kaur S, Ahuja P, Kapil L, Sharma D, Singh C, Singh A
Mol Biol Rep
. 2024 Aug;
51(1):930.
PMID: 39174728
Background: Among the three most used anticancer drugs, cyclophosphamide, Adriamycin, and 5-Fluorouracil (CAF), the most significant outcome is chemobrain, caused by increased oxidative stress, inflammatory insult, and mitochondrial dysfunction. Objective:...
6.
Kaur S, K M, Sharma A, Giridharan V, Dandekar M
Inflammopharmacology
. 2024 Aug;
32(5):2781-2800.
PMID: 39167311
The neurobiology of Alzheimer's disease (AD) is unclear due to its multifactorial nature. Although a wide range of studies revealed several pathomechanisms of AD, dementia is yet unmanageable with current...
7.
Singh A, Kumar V, Langeh U, Kapil L, Kaur S, Rana N, et al.
J Mol Histol
. 2024 Jul;
55(4):599-625.
PMID: 39042217
Today, we critically need alternative therapeutic options for chemotherapy-induced cognitive impairment (CICI), often known as chemo brain. Mitochondrial dysfunction and oxidative stress are two of the primary processes that contribute...
8.
Mukherjee A, Singh B, Kaur S, Sharma M, Ferreira de Araujo A, de Araujo Pereira A, et al.
Microbiol Res
. 2024 Jul;
286:127780.
PMID: 38970905
In recent years, research into the complex interactions and crosstalk between plants and their associated microbiota, collectively known as the plant microbiome has revealed the pivotal role of microbial communities...
9.
Ghosh A, Basu D, Kaur S, Naik S, Bn S, Subodh B, et al.
J Stud Alcohol Drugs
. 2024 Jun;
86(1):48-57.
PMID: 38837914
Objective: The COVID-19 pandemic has affected the availability of and access to medications for opioid dependence (OD). We examined the monthly trends in new buprenorphine/naloxone (BNX) treatment episodes, number of...
10.
Shukla D, Kaur S, Singh A, Narang R, Singh C
Drug Deliv Transl Res
. 2024 Apr;
14(12):3422-3437.
PMID: 38573496
Chemotherapy-induced cognitive impairment (CICI), also known as "chemobrain," is a common side effect of breast cancer therapy which causes oxidative stress and generation of reactive oxygen species (ROS). Ferulic acid...